学者信息
已发表成果：
WOK 论文 52 篇;中文核心 34 篇;其它论文 11 篇;专利发明 16 个;
-
Unlocking the potential of bispecific ADCs for targeted cancer therapy
FRONTIERS OF MEDICINE,2095-0217,2024-07-23.
Zeng, Hongye; Ning, Wenjing; Liu, Xue; Luo, Wenxin; Xia, Ningshao
WOS:001274312700002 10.1007/s11684-024-1072-8
收录情况：SCIE -
Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
ACTA PHARMACEUTICA SINICA B,2211-3835,2024-06.
Qin, Xiaojing; Ning, Wenjing; Liu, Han; Liu, Xue; Luo, Wenxin; Xia, Ningshao
WOS:001247704400001 10.1016/j.apsb.2024.03.027
收录情况：SCIE -
A Dual-domain Engineered Antibody for Efficient HBV Suppression and Immune Responses Restoration
ADVANCED SCIENCE,,2024-02-11.
Jiang, Yichao; Chen, Xiaoqing; Ye, Xinya; Wen, Can; Xu, Tao; Yu, Chao; Ning, Wenjing; Wang, Guosong...
WOS:001159352000001 EI:20240715535897 10.1002/advs.202305316
收录情况：SCIE、EI
-
抗体靶向的免疫激动性药物在肿瘤免疫治疗中的研究进展
中国生物工程杂志,1671-8135,2024-06-25.
汪雅琳;陈小青;许涛;刘雪;罗文新
CSCD核心库 -
三特异性抗体在肿瘤免疫治疗中的研究进展
生命科学,1004-0374,2024-04-02.
许林;宁文静;刘雪;罗文新
CSCD核心库 -
纳米抗体在自身免疫性疾病中的应用
中国免疫学杂志,1000-484X,2024-01-20.
敖正宏;王玥;梅雅贤;罗文新
CSCD核心库